The Latest Cardiac and Vascular News
ABBOTT PARK, Ill., Oct. 23, 2017 /PRNewswire/ — Abbott (NYSE: ABT) has secured U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx™ Insertable Cardiac Monitor (ICM), the world’s first and only smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias. With FDA clearance Abbott can now provide U.S. patients a new […]
NEWTOWN, Pa., Oct. 23, 2017 /PRNewswire/ — Micro Interventional Devices, Inc. announced today the second successful implantation of its MIA (Minimally Invasive Annuloplasty) technology. The patient was enrolled in the first arm of the STTAR (Study of Transcatheter Tricuspid Annular Repair) clinical trial studying the safety and efficacy of MID’s MIA device […]
DUBLIN – October 23, 2017 – Medtronic (NYSE:MDT) today announced the first patient implant in the APOLLO Trial – the pivotal trial designed to evaluate the Intrepid(TM) TMVR system following receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA). As the first-ever pivotal trial for transcatheter […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will incorporate the HeartFlow® FFRct Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the CorPath® GRX System to evaluate the feasibility and utility of clinical decision support. “We are […]
SANTA ROSA, Calif.–(BUSINESS WIRE)– Claret Medical, developer of the Sentinel® Cerebral Protection System, the first FDA-cleared cerebral protection device for transcatheter aortic valve replacement (TAVR), today announced that it has closed on a Series C financing of $14.5 million led by Lightstone Ventures, with participation from existing investors Easton Capital, HealthCor Partners, […]
DANVERS, Mass., Oct. 19, 2017 (GLOBE NEWSWIRE) — Abiomed Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 30 presentations potentially featuring the Impella® line of heart pumps scheduled during the 29th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of […]
REDWOOD CITY, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced initiation of INSIGHT, a prospective, global, single arm, multi-center study to evaluate the safety and effectiveness of the Pantheris® Lumivascular Atherectomy System for treating in-stent […]
FRANKLIN LAKES, N.J., Oct. 18, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s clearance by the European Commission for BD to acquire C.R. Bard (NYSE: BCR), contingent on BD divesting its soft tissue core needle biopsy product line: “We […]
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within the emerging electrophysiology (EP) marketplace, announced today that they have made significant progress towards commercialization of their proprietary PURE EP System. The […]
MyoVista® hsECG™ Utilizes Wavelet Technology to Detect Cardiac Diastolic Dysfunction SOUTHLAKE, Texas, Oct. 19, 2017 /PRNewswire-USNewswire/ — HeartSciences announced today that the company will launch its MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device in Canada at the Canadian Cardiovascular Congress (CCC) in Vancouver on October 21-24. The MyoVista hsECG is now available in Canada, where it received Health Canada Medical […]
